Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masaya Ito
Observed name:
Ito, Masaya
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institution:
Tokyo Metropolitan Komagome Hospital
ORCID:
0000-0002-0230-6367
Observed ORCID:
0000-0002-0230-6367
OpenAlex ID:
A5074894722
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
2023
·
Soichiro Yoshida
, Taro Takahara
, et al.
·
BMC Urology
·
9
PDF
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
3
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic review
2026
·
Takahiko Soma
, Kosuke Takemura
, et al.
·
BMJ Oncology
·
2
PDF
Dramatic improvement after palliative whole-liver radiotherapy for liver damage caused by diffuse liver metastases from castration-resistant prostate cancer: A case report
2023
·
Yumi Ogoshi
, Kei Ito
, et al.
·
1
PDF
Adverse impact of bladder biopsy on the rate of intravesical recurrences following radical nephroureterectomy for upper tract urothelial carcinoma
2026
·
Tomonori Kanagawa
, Ichiro Yonese
, et al.
·
Japanese Journal of Clinical Oncology
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinations
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Urology and Nephrology
Show more works
View as search
Works count:
7
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type